Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP

Davion completed the purchase of intellectual property tied to WoundSkan and the Spektra Lateral Flo

Davion Healthcare Plc completed a $25M acquisition of Humaskan’s IP for WoundSkan and Spektra, paying $2.5M cash and issuing 1,730,770 shares at $13.00. Shares are subject to a 90-day deferral from Jan 20, 2027 and volume-limited sales for 90 days after.Material DetailsContext by AI AnalystFirst ac…